Zyga Technology, a Minneapolis-based minimally invasive spine surgical solutions company, received FDA 510(k) clearance for its SImmetry sacroiliac joint fusion system, according to a company news release.
The system is indicated for treating conditions such as degenerative sacroilitis and sacroiliac joint disruptions. The system includes a range of threaded, cannulated implants and associated instrumentation.
The implants are designed to transfix the sacrum and ilium to provide stability for bony fusion.
Read the Zyga Technology release on the SImmetry sacroiliac joint fusion system.
Read other coverage on spine surgery systems:
- 12 Spine Devices Receive FDA 510(k) Clearance in November
- DePuy Spine Launches MOUNTAINEER Laminopasty System
- SpinalVu Begins Production on Cervical and Lumbar Interbody Systems
The system is indicated for treating conditions such as degenerative sacroilitis and sacroiliac joint disruptions. The system includes a range of threaded, cannulated implants and associated instrumentation.
The implants are designed to transfix the sacrum and ilium to provide stability for bony fusion.
Read the Zyga Technology release on the SImmetry sacroiliac joint fusion system.
Read other coverage on spine surgery systems:
- 12 Spine Devices Receive FDA 510(k) Clearance in November
- DePuy Spine Launches MOUNTAINEER Laminopasty System
- SpinalVu Begins Production on Cervical and Lumbar Interbody Systems